Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians

International Journal of Mental Health Nursing
Kay Hodge, Sean Jespersen

Abstract

This study sought to clarify the prevalence of various side-effects experienced by consumers taking clozapine (n = 27) and to elucidate the impact of clozapine on their quality of life. Responses of consumers were contrasted with those of clinicians to highlight any discrepancies between the two groups, thus providing a focus for the improvement of clinical practice. Consumers completed a demographic questionnaire, the Liverpool University Neuroleptic Side-Effect Rating Scale. They next took part in a semistructured interview, which explored their attitudes to clozapine treatment. File searches provided historical data for antipsychotic use before the prescription of clozapine. Clinicians completed the same instruments and submitted them by mail. Most clinicians overestimated the prevalence and severity of clozapine side-effects. Consumers reported drooling mouth as the most prevalent and severe side-effect, whereas clinicians estimated that difficulty staying awake was the most prevalent side-effect, and the most severe side-effect was sleeping too much. Clinicians and consumers agreed that clozapine lifts mood. Only 19% of consumers were unhappy about blood tests, whereas 52% of clinicians estimated that consumers were unhapp...Continue Reading

References

Apr 1, 1983·Archives of General Psychiatry·A F Lehman
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·J C DayR P Bentall
May 1, 1995·The Journal of Nervous and Mental Disease·P W Corrigan, B Buican
Apr 27, 2000·Psychiatric Services : a Journal of the American Psychiatric Association·J Waserman, M Criollo
Apr 18, 2001·Psychological Medicine·M C AngermeyerS Priebe
Mar 11, 2003·Acta Cardiologica·Gaston BaeleUNKNOWN Belgian Working Group on Angiology
Jan 1, 1995·European Psychiatry : the Journal of the Association of European Psychiatrists·H Meltzer
Nov 1, 2003·Current Therapeutic Research, Clinical and Experimental·Antonietta MartelliGiovanni Brambilla

❮ Previous
Next ❯

Citations

Dec 3, 2011·Indian Journal of Psychiatry·Mahavir Sri AgarwalGanesan Venkatsubramanian
Jan 26, 2016·Archives of Psychiatric Nursing·Marc De HertDan Cohen
Sep 17, 2014·Nordic Journal of Psychiatry·Niko SeppäläOlli Kampman
May 14, 2011·Acta Psychiatrica Scandinavica·John M Kane
Apr 19, 2012·Acta Psychiatrica Scandinavica·P R Falzer, D M Garman
May 15, 2010·Journal of Psychiatric and Mental Health Nursing·R Lakeman
Jan 16, 2010·International Journal of Mental Health Nursing·Joy A DuxburyPamela Barnes
Sep 6, 2013·Acta Psychiatrica Scandinavica·S GeeD Taylor
Apr 20, 2016·Schizophrenia Research·Hiroyoshi TakeuchiGary Remington
Aug 5, 2016·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Ippei TakeuchiHiroyuki Kamei
Jul 23, 2015·Therapeutic Advances in Psychopharmacology·Inti QurashiImran Chaudhry
Nov 20, 2018·Australian Journal of Primary Health·Kate MurphyAmanda J Wheeler
Jan 8, 2019·International Clinical Psychopharmacology·Aviv SegevJames H MacCabe
Apr 9, 2020·Acta Psychiatrica Scandinavica·H Verdoux, C Quiles
Apr 24, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Alexander Panickacheril JohnArun Dominic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Developmental Medicine and Child Neurology
Corrie E ErasmusJan J Rotteveel
Current Opinion in Otolaryngology & Head and Neck Surgery
Devyani Lal, Andrew J Hotaling
Journal of Behavior Therapy and Experimental Psychiatry
Jan J W Van der BurgJan J Rotteveel
© 2021 Meta ULC. All rights reserved